SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Angstrom Pharmaceuticals Announces Publication of the Discovery of the Cellular Target of Its A6 Phase II Clinical Compound Resulting From Its Joint Study With Apricus Biosciences